269 related articles for article (PubMed ID: 21094559)
1. Optimal anatomic coverage for CT in staging lung cancer: lessons from PET-CT correlation.
Gross BH; Brown RK; Kalemkerian GP
Lung Cancer; 2011 Jul; 73(1):59-62. PubMed ID: 21094559
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of advantages of positron emission tomography over computed tomography for N-staging in lung cancer patients.
Ebihara A; Nomori H; Watanabe K; Ohtsuka T; Naruke T; Uno K; Kuwahira I; Eguchi K
Jpn J Clin Oncol; 2006 Nov; 36(11):694-8. PubMed ID: 17068084
[TBL] [Abstract][Full Text] [Related]
3. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.
Lardinois D; Weder W; Hany TF; Kamel EM; Korom S; Seifert B; von Schulthess GK; Steinert HC
N Engl J Med; 2003 Jun; 348(25):2500-7. PubMed ID: 12815135
[TBL] [Abstract][Full Text] [Related]
4. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
5. [Comparing serum tumor antigen detection combined with CT scan with PET-CT for lung cancer diagnosis].
Zhang X; Li TR; Chen ZS; Ouyang XN
Ai Zheng; 2006 Jan; 25(1):66-8. PubMed ID: 16405752
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929
[TBL] [Abstract][Full Text] [Related]
7. Stage migration in planning PET/CT scans in patients due to receive radiotherapy for non-small-cell lung cancer.
Geiger GA; Kim MB; Xanthopoulos EP; Pryma DA; Grover S; Plastaras JP; Langer CJ; Simone CB; Rengan R
Clin Lung Cancer; 2014 Jan; 15(1):79-85. PubMed ID: 24238934
[TBL] [Abstract][Full Text] [Related]
8. Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer.
von Haag DW; Follette DM; Roberts PF; Shelton D; Segel LD; Taylor TM
J Surg Res; 2002 Apr; 103(2):160-4. PubMed ID: 11922730
[TBL] [Abstract][Full Text] [Related]
9. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.
Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Xing L; Zhao D; Mu D; Sun X; Fang Y; Huang Y; Li W
Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978
[TBL] [Abstract][Full Text] [Related]
10. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer.
Cerfolio RJ; Ojha B; Bryant AS; Raghuveer V; Mountz JM; Bartolucci AA
Ann Thorac Surg; 2004 Sep; 78(3):1017-23; discussion 1017-23. PubMed ID: 15337041
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer staging: the value of ipsilateral scalene lymph node biopsy performed at mediastinoscopy.
Lee JD; Ginsberg RJ
Ann Thorac Surg; 1996 Aug; 62(2):338-41. PubMed ID: 8694587
[TBL] [Abstract][Full Text] [Related]
12. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.
Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562
[TBL] [Abstract][Full Text] [Related]
13. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study.
Cerfolio RJ; Bryant AS; Ojha B
J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1229-35. PubMed ID: 16733150
[TBL] [Abstract][Full Text] [Related]
14. Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study.
Kaira K; Oriuchi N; Otani Y; Shimizu K; Tanaka S; Imai H; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Dobashi K; Kanai Y; Endou H; Nakajima T; Endo K; Mori M
Clin Cancer Res; 2007 Nov; 13(21):6369-78. PubMed ID: 17975149
[TBL] [Abstract][Full Text] [Related]
15. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.
Pfau PR; Perlman SB; Stanko P; Frick TJ; Gopal DV; Said A; Zhang Z; Weigel T
Gastrointest Endosc; 2007 Mar; 65(3):377-84. PubMed ID: 17321235
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography-computed tomography for postoperative surveillance in non-small cell lung cancer.
Choi SH; Kim YT; Kim SK; Kang KW; Goo JM; Kang CH; Kim JH
Ann Thorac Surg; 2011 Nov; 92(5):1826-32; discussion 1832. PubMed ID: 22051278
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer.
Lee PC; Port JL; Korst RJ; Liss Y; Meherally DN; Altorki NK
Ann Thorac Surg; 2007 Jul; 84(1):177-81. PubMed ID: 17588407
[TBL] [Abstract][Full Text] [Related]
18. Can positron emission tomography be used as a staging tool for small-cell lung cancer?
Vinjamuri M; Craig M; Campbell-Fontaine A; Almubarak M; Gupta N; Rogers JS
Clin Lung Cancer; 2008 Jan; 9(1):30-4. PubMed ID: 18282355
[TBL] [Abstract][Full Text] [Related]
19. Value of 11C-choline PET/CT for lung cancer diagnosis and the relation between choline metabolism and proliferation of cancer cells.
Li M; Peng Z; Liu Q; Sun J; Yao S; Liu Q
Oncol Rep; 2013 Jan; 29(1):205-11. PubMed ID: 23124523
[TBL] [Abstract][Full Text] [Related]
20. Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration.
De Wever W; Stroobants S; Coolen J; Verschakelen JA
Eur Respir J; 2009 Jan; 33(1):201-12. PubMed ID: 19118231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
